SCHEMBL110567

SCHEMBL110567

N#Cc1ccc(N)cc1C(F)(F)F

nearest known ligand 0.56

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
AR P10275 19/20 0.56
GLA P06280 1/20 0.55
POLB P06746 1/20 0.55
GAA P10253 1/20 0.55
TSHR P16473 1/20 0.55
PGR P06401 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29396844 1.00 AR (0.56) ARGLAPOLBGAATSHR
SCHEMBL15320326 0.85 AR (0.45) ARGLAPOLBGAATSHR
SCHEMBL15319977 0.85 AR (0.45) ARGLAPOLBGAATSHR
SCHEMBL15319981 0.85 KDM4E (0.49) ARGLAPOLBGAATSHR
SCHEMBL30084901 0.84 GLA (0.55) ARGLAPOLBGAATSHR
SCHEMBL324114 0.84 GLA (0.55) ARGLAPOLBGAATSHR
SCHEMBL28932082 0.81 AR (0.65) AR
SCHEMBL31019374 0.80 GAA (0.55) ARGLAPOLBGAATSHR
SCHEMBL1762580 0.80 GAA (0.55) ARGLAPOLBGAATSHR
SCHEMBL1772784 0.80 KDM4E (0.52) ARGLAPOLBGAATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1722 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119409577-B Preparation method of 2-fluoro-4-nitrobenzoic acid 山东极地医药科技有限公司 2025-03-21 CN claimed
CN-119409577-A Preparation method of 2-fluoro-4-nitrobenzoic acid 山东极地医药科技有限公司 2025-02-11 CN claimed
CN-115394924-B Organic-inorganic hybrid perovskite solar cell based on interface modification layer 太原理工大学 2025-01-24 CN claimed
CN-118619837-A Preparation method of 2-trifluoromethyl-4-aminobenzoic acid 江西金丰药业有限公司 2024-09-10 CN claimed
CN-116199633-B Method for preparing revalutamide 甘肃省化工研究院有限责任公司 2024-05-31 CN claimed
CN-115181043-B Method for preparing 4-isothiocyanato-2- (trifluoromethyl) benzonitrile by continuous flow 爱斯特(成都)生物制药股份有限公司 2024-05-07 CN claimed
CN-116082246-B Synthesis method of ethylene thiourea derivative 长沙泽达医药科技有限公司 2023-11-21 CN claimed
CN-116199633-A Method for preparing revalutamide 甘肃省化工研究院有限责任公司 2023-06-02 CN claimed
CN-116082246-A Synthesis method of ethylene thiourea derivative 长沙泽达医药科技有限公司 2023-05-09 CN claimed
CN-113717086-B Preparation method of green and environment-friendly 4-isothiocyanato-2- (trifluoromethyl) benzonitrile 江西金丰药业有限公司 2023-03-10 CN claimed
WO-2003059899-A1 GLUCOCORTICOID MIMETICS, METHODS OF MAKING THEM, PHARMACEUTICAL FORMULATIONS CONTAINING THEM AND USES THEREOF BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2003-07-24 WO claimed
US-6583306-B1 Forming dioxolane derivative of citramalic acid; replacing free carboxylic acid with leaving group; coupling with hydroxyl, amino, thiol, sulphinyl or sulphonyl reactive compound; deprotecting; amidation with aniline derivitive NOBEX CORPORATION 2003-06-24 US claimed
CN-1409702-A Methods for asymmetrically synthesizing enantiomer of casodex, its derivatives and intermediate thereof NOBEX CORP (US) 2003-04-09 CN claimed
EP-1189898-B1 PROCESS FOR THE SYNTHESIS OF N-(4-CYANO-3-TRIFLUOROMETHYLPHENYL)-3-(4-FLUOROPHENYLSULPHONYL)-2-HYDROXY-2-METHYLPROPIONAMIDE RICHTER GEDEON VEGYESZET (HU) 2003-03-12 EP claimed
US-20030045741-A1 Novel process for preparing rac-bicalutamide and its intermediates TEVA GYOGYSZERGYAR ZARTKORUEN MUKODO RESZVENYTARSASAG (HU) 2003-03-06 US claimed
WO-2002100339-A2 NOVEL PROCESS FOR PREPARING RAC-BICALUTAMIDE AND ITS INTERMEDIATES BIOGAL GYOGYSZERGYAR RT. (HU) 2002-12-19 WO claimed
EP-1222165-A2 METHODS OF ASYMMETRICALLY SYNTHESIZING ENANTIOMERS OF CASODEX, ITS DERIVATIVES AND INTERMEDIATES THEREOF Nobex Corporation (US) 2002-07-17 EP claimed
EP-1189898-A1 PROCESS FOR THE SYNTHESIS OF N-(4-CYANO-3-TRIFLUOROMETHYLPHENYL)-3-(4-FLUOROPHENYLSULPHONYL)-2-HYDROXY-2-METHYLPROPIONAMIDE RICHTER GEDEON VEGYESZETI GYAR R.T. (HU) 2002-03-27 EP claimed
WO-2001028990-A2 METHODS OF ASYMMETRICALLY SYNTHESIZING ENANTIOMERS OF CASODEX, ITS DERIVATIVES AND INTERMEDIATES THEREOF NOBEX CORPORATION (US) 2001-04-26 WO claimed
WO-2001000608-A1 PROCESS FOR THE SYNTHESIS OF N-(4-CYANO-3-TRIFLUOROMETHYLPHENYL)-3-(4-FLUOROPHENYLSULFONYL)-2-HYDROXY-2-METHYLPROPIONAMIDE Richter Gedeon Vegyészeti Gyár Rt. (HU) 2001-01-04 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030045741-A1 Novel process for preparing rac-bicalutamide and its intermediates RAC2, RAC3, RAC1 AR 78/4885GLA 4077/4885POLB 2012/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.